ask="2.02"
ask_size="500"
average_daily_volume="2170830"
bid="1.90"
bid_size="3000"
book_value="1.37"
change="+0.06"
change_from_200_day_moving_average="-2.69"
change_from_50_day_moving_average="0.25"
change_from_52_week_high="-6.20"
change_From_52_week_low="0.82"
change_in_percent="+3.06%"
close="2.02"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.34"
ebitda="-82.29M"
eps_estimate_current_year="-0.39"
eps_estimate_next_quarter="-0.14"
eps_estimate_next_year="-0.56"
ex_dividend_date="N/A"
float_shares="63129000"
high="2.12"
high_52_weeks="8.22"
last_trade_date="2/8/2017"
last_trade_price="2.02"
last_trade_size="62325"
last_trade_time="4:00pm"
low="1.91"
low_52_weeks="1.20"
market_capitalization="149.83M"
moving_average_200_day="4.71"
moving_average_50_day="1.77"
name="Arrowhead Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="1.80"
open="1.99"
pe_ratio="N/A"
peg_ratio="-0.58"
percent_change_from_200_day_moving_average="-57.11%"
percent_change_from_50_day_moving_average="+14.03%"
percent_change_from_52_week_high="-75.43%"
percent_change_from_52_week_low="+68.33%"
previous_close="1.96"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.43"
price_per_sales="918.19"
revenue="158333.00"
shares_outstanding="74173000"
short_ratio="4.40"
stock_exchange="NMS"
symbol="ARWR"
volume="1375026"
weeks_range_52="1.20 - 8.22"
